STAAR Surgical Company
STAA
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats faā¦ read more
Healthcare
Medical Instruments & Supplies
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$25.14
Price+4.66%
$1.12
1Y
Price
Market Cap
$1.243b
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+27.9%
EBITDA Margin+9.4%
Net Profit Margin+1.9%
Free Cash Flow MarginRevenue
$230.591m
-26.5%
1y CAGR-5.3%
3y CAGR+1.9%
5y CAGREarnings
-$96.367m
-376.9%
1y CAGR-205.9%
3y CAGR-143.4%
5y CAGREPS
-$1.95
-375.6%
1y CAGR-205.7%
3y CAGR-139.3%
5y CAGRBook Value
$353.780m
$456.362m
Assets$102.582m
Liabilities$39.117m
DebtDebt to Assets
8.6%
-0.7x
Debt to EBITDAFree Cash Flow
-$39.542m
-415.6%
1y CAGR-216.5%
3y CAGR-172.8%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company